HOLLY SCHWEITZER: Open Payments
NPI 1023348265 · COLUMBUS, OH. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$27,521 in 82 payments from 9 companies in 2025. Trend: 2023 $20,839 · 2024 $29,273 · 2025 $27,521
Speaker / faculty: $24,258Travel & lodging: $2,185Food & beverage: $1,077
| Company | Payments | Amount |
|---|---|---|
| Otsuka America Pharmaceutical, Inc. | 55 | $27,123 |
| ABBVIE INC. | 16 | $199 |
| Lundbeck LLC | 4 | $76 |
| Janssen Pharmaceuticals, Inc | 2 | $33 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $21 |
| Tris Pharma Inc | 1 | $20 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $18 |
| Axsome Therapeutics, Inc. | 1 | $18 |
| Vanda Pharmaceuticals Inc. | 1 | $15 |
Products named: REXULTI, VRAYLAR, SPRAVATO, TRINTELLIX, Dyanavel XR, CAPLYTA, Auvelity, FANAPT.
Industry payments across OH — which companies pay providers there.
